Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 497 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Poorer Survival in Obese Colorectal Cancer Patients Possibly Linked to Lower... July 2, 2021 FDA Approves Selumetinib for Paediatric Patients 1 Year of Age and... September 25, 2025 Limited Efficacy of Nivolumab plus Ipilimumab in Adenoid Cystic Carcinomas, but... September 11, 2023 The Nobel Prize winner helping us treat children’s cancers November 8, 2022 Load more HOT NEWS Screening for Many Cancers with One Test: Uncertainty Abounds Carvykti Approval Marks Second CAR T-Cell Therapy for Multiple Myeloma Screening People at High Risk for Pancreatic Cancer May Help Them... How I Learned to Cope With Survivor’s Guilt After Cancer
